1. Younglai EV, Holloway AC, Foster WG. Environmental and occupational factors affecting fertility and IVF success. Hum Reprod Update 2005; 11: 43-57. [
DOI:10.1093/humupd/dmh055]
2. Minge CE, Robker RL, Norman RJ. PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. PPAR Res 2008; 2008: 243791. [
DOI:10.1155/2008/243791]
3. Chinetti-Gbaguidi G, Fruchart JC, Staels B. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy. Curr Opin Pharmacol 2005; 5: 177-183. [
DOI:10.1016/j.coph.2004.11.004]
4. Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006; 189: 199-209. [
DOI:10.1677/joe.1.06667]
5. Komar CM, Braissant O, Wahli W, Curry TE Jr. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001; 142: 4831-4838. [
DOI:10.1210/endo.142.11.8429]
6. Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R, Goodarzi MO. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril 2007; 87: 862-869. [
DOI:10.1016/j.fertnstert.2006.10.006]
7. Fan W, Yanase T, Morinaga H, Mu YM, Nomura M, Okabe T, et al. Activation of peroxisome proliferator-activated receptor-gamma and retinoid X receptor inhibits aromatase transcription via nuclear factor-kappaB. Endocrinology 2005; 146: 85-92. [
DOI:10.1210/en.2004-1046]
8. Shah DK, Menon KM, Cabrera LM, Vahratian A, Kavoussi SK, Lebovic DI. Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro. Fertil Steril 2010; 93: 2042-2047. [
DOI:10.1016/j.fertnstert.2009.02.059]
9. Barak Y, Sadovsky Y, Shalom-Barak T. PPAR Signaling in Placental Development and Function. PPAR Res 2008; 2008: 142082. [
DOI:10.1155/2008/142082]
10. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, et al. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem 2002; 277: 17830-17835. [
DOI:10.1074/jbc.M200186200]
11. Rees WD, McNeil CJ, Maloney CA. The Roles of PPARs in the Fetal Origins of Metabolic Health and Disease. PPAR Res 2008; 2008: 459030. [
DOI:10.1155/2008/459030]
12. Faut M, Elia EM, Parborell F, Cugnata NM, Tesone M, Motta AB. Peroxisome proliferator-activated receptor gamma and early folliculogenesis during an acute hyperandrogenism condition. Fertil Steril 2011; 95: 333-337. [
DOI:10.1016/j.fertnstert.2010.07.1083]
13. Lovekamp-Swan T, Chaffin CL. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Mol Cell Endocrinol 2005; 233: 15-24. [
DOI:10.1016/j.mce.2005.01.011]
14. Froment P, Fabre S, Dupont J, Pisselet C, Chesneau D, Staels B, et al. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69: 1665-1674. [
DOI:10.1095/biolreprod.103.017244]
15. van Beekum O, Fleskens V, Kalkhoven E. Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator. Obesity (Silver Spring) 2009; 17: 213-219. [
DOI:10.1038/oby.2008.473]